Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | TK1 | P04183 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | ALB | P02768 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.57 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9201376 | 1.00 | POLB (0.63) | POLBTK1LMNATSHRALB | |
| Ammonia Solution, Strong SCHEMBL30922192 | 0.99 | POLB (0.62) | POLBTK1LMNATSHRALB | |
| SCHEMBL547923 | 0.88 | POLB (0.66) | POLBTK1 | |
| SCHEMBL9229137 | 0.88 | TYMS (0.54) | LMNA | |
| SCHEMBL10380716 | 0.88 | TK1 (0.58) | POLBTK1LMNATSHRALB | |
| SCHEMBL27677810 | 0.87 | POLB (0.57) | POLBTK1LMNATSHRALB | |
| SCHEMBL1360475 | 0.86 | TK1 (0.61) | POLBTK1LMNATSHRALB | |
| Thymidine Monophosphate SCHEMBL17075779 | 0.86 | POLB (0.74) | POLBTK1 | |
| Thymidine Monophosphate SCHEMBL9559854 | 0.84 | POLB (0.78) | POLBTK1 | |
| SCHEMBL17667452 | 0.84 | TK1 (0.68) | POLBTK1LMNATSHRALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12333 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630593-B2 | Method of killing leukemia cells by administration of recombinant'Y3 proteins | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-05-19 | — | — | US | claimed |
| US-20260124290-A1 | HIV Immunogens, Vaccines, and Methods Related Thereto | UNIV EMORY (US) | 2026-05-07 | — | — | US | claimed |
| US-20260091068-A1 | METHODS FOR TREATING AND PREVENTING DISEASES | Tets, Viktor Veniaminovich (US) | 2026-04-02 | — | — | US | claimed |
| US-20260083768-A1 | INFLAMMASOME INHIBITION FOR NEUROPROTECTION | AMBATI JAYAKRISHNA (US) | 2026-03-26 | — | — | US | claimed |
| EP-4698174-A1 | DOSING REGIMEN OF CAPSID INHIBITOR | GILEAD SCIENCES, INC. (US) | 2026-02-25 | — | — | EP | claimed |
| US-20260021101-A1 | COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDERS | BROWN UNIVERSITY (US) | 2026-01-22 | — | — | US | claimed |
| EP-3212200-B2 | USE OF AN INVERSE TRANSCRIPTASE INHIBITOR FOR THE TREATMENT AND PREVENTION OF DEGENERATIVE DISEASES | CENTRE NAT RECH SCIENT (FR) | 2025-12-24 | — | — | EP | claimed |
| US-12459989-B2 | Antibody therapies for human immunodeficiency virus (HIV) | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2025-11-04 | — | — | US | claimed |
| EP-4634679-A1 | SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED MATERIALS | NVision Imaging Technologies GmbH (DE) | 2025-10-22 | — | — | EP | claimed |
| US-20250283074-A1 | CLUSTERIN OVEREXPRESSION IN ALZHEIMER’S DISEASE | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2025-09-11 | — | — | US | claimed |
| EP-0316345-A4 | LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE. | LIPOSOME TECHNOLOGY INC (US) | 1989-05-16 | — | — | EP | claimed |
| WO-1989002733-A1 | LIPOSOMAL NUCLEOSIDE ANALOGUES FOR TREATING AIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1989-04-06 | — | — | WO | claimed |
| US-4804651-A | AZIDOTHYMIDINE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1989-02-14 | — | — | US | claimed |
| EP-0301206-A2 | Use of azidothymidine in the treatment of psoriasis | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1989-02-01 | — | — | EP | claimed |
| WO-1988009181-A2 | MONOCLONAL ANTIBODIES NEUTRALIZING HIV-1 | TANOX BIOSYSTEMS, INC. (US) | 1988-12-01 | — | — | WO | claimed |
| EP-0286224-A2 | Treatment of human viral infection by dsRNA combined with viral inhibitors | HEM PHARMACEUTICALS CORP. (US) | 1988-10-12 | — | — | EP | claimed |
| WO-1988007532-A1 | 2',3' DIDEOXYRIBOFURANOXIDE DERIVATIVES | NYCOMED A.S. (NO) | 1988-10-06 | — | — | WO | claimed |
| EP-0260428-A2 | Cationic surfactants and pharmaceutical compositions containing them | MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG (DE) | 1988-03-23 | — | — | EP | claimed |
| WO-1988000824-A1 | LIPOSOMES WITH ENHANCED RETENTION ON MUCOSAL TISSUE | LIPOSOME TECHNOLOGY, INC. (US) | 1988-02-11 | — | — | WO | claimed |
| EP-0232155-A2 | Drug delivery system | ELAN CORPORATION PLC (IE) | 1987-08-12 | — | — | EP | claimed |